PROCEPT BioRobotics Corporation
PRCTNASDAQHealthcare● Active
$28.60
+$0.77(+2.77%)
Market Cap$1.6B
P/E Ratio—
52W High$66.85
52W Low$19.35
PROCEPT BioRobotics Corporation (PRCT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PRCT · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.31B | $0.22B | $0.14B | $0.08B | $0.03B |
| Cost of Revenue | $0.11B | $0.09B | $0.07B | $0.04B | $0.02B |
| Gross Profit | $0.20B | $0.14B | $0.07B | $0.04B | $0.02B |
| Gross Margin %(computed) | 63.70% | 61.07% | 52.17% | 49.44% | 46.02% |
| Operating Expenses | |||||
| R&D Expenses | $0.07B | $0.06B | $0.05B | $0.03B | $0.02B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.30B | $0.23B | $0.18B | $0.12B | $0.07B |
| Operating Income | ($0.10B) | ($0.10B) | ($0.11B) | ($0.08B) | ($0.05B) |
| Operating Margin %(computed) | -33.71% | -43.04% | -80.16% | -107.61% | -157.12% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Income Before Tax | ($0.10B) | ($0.09B) | ($0.11B) | ($0.09B) | ($0.06B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.10B) | ($0.09B) | ($0.11B) | ($0.09B) | ($0.06B) |
| Net Margin %(computed) | -31.02% | -40.72% | -77.76% | -116.18% | -173.62% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.72 | $-1.75 | $-2.24 | $-1.96 | $-1.37 |
| Wtd Avg Shares | 0.06B | 0.05B | 0.05B | 0.04B | 0.04B |
| EBITDA | ($0.10B) | ($0.08B) | ($0.10B) | ($0.08B) | ($0.05B) |
| EBITDA Margin %(computed) | -31.64% | -36.52% | -72.03% | -105.49% | -147.13% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more PROCEPT BioRobotics Corporation data
About PROCEPT BioRobotics Corporation (PRCT) Income Statement
PROCEPT BioRobotics Corporation (PRCT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PRCT reported revenue of $0.31B, gross profit of $0.20B (gross margin 63.70%), and net income of ($0.10B) — a net profit margin of -31.02%.
Frequently asked questions
PRCT · 4 questionsPROCEPT BioRobotics Corporation (PRCT) reported revenue of $0.31B for 2025, up 37.2% year-over-year.
PRCT revenuePRCT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08